TL;DR
- •Teachers report some of the highest occupational burnout rates of any profession — roughly 44% of K-12 teachers report frequent burnout, and depression and anxiety rates have climbed sharply post-pandemic.
- •The combination of emotional labor with students, administrative pressure, parent communication, and chronic underpay produces a profile that doesn't respond fully to summer break.
- •Telehealth ketamine therapy fits the teacher schedule — sessions evenings or weekends, no need to take time off school, completely private from district systems.
- •Tovani is direct-pay ($349/month, HSA/FSA eligible) — bypasses any district insurance record. License renewals do not require disclosure of standard outpatient mental health treatment in most states.
- •Most teacher-patients say what mattered most was: scheduling around prep periods and end-of-day; same physician every visit; treatment at home with no school-community visibility.
- •For treatment-resistant cases where SSRIs and therapy alone haven't produced enough response — common in chronic burnout — ketamine's rapid-action mechanism is increasingly the next step.
Few professions ask for as much emotional labor as teaching, and the data reflect it, with roughly 44% of K-12 teachers reporting frequent burnout and depression and anxiety rates climbing sharply since the pandemic. What makes the teacher's stress distinct is its breadth across a single day. You manage the emotional weather of a hundred or more students, field parent communication weighted toward complaints, and absorb the difficult home situations students carry in, all while testing pressure and paperwork crowd out the teaching you trained for. Chronic underpay sits underneath everything.
The thing people get wrong about teacher burnout is assuming summer fixes it. By the time many educators reach me, they have taken the break and found the symptoms simply waited for them in August. When rest and schedule changes have not produced enough recovery, what remains is often clinical depression normalized as just the cost of the job. Standard care also collides with the school day, since sessions during business hours mean a substitute, and a local clinic carries real risk of running into a student or parent.
At-home telehealth ketamine therapy is shaped around the academic calendar rather than against it. Sessions happen evenings or weekends, so there is no substitute to arrange and no sick leave to spend, and they take place in your own home with no chance of being seen by students or parents. You see the same physician each visit, and the model fits whether you start mid-year or use summer for the initial phase. Tovani is direct-pay, so nothing is tied to your district plan. Ketamine does not work for everyone and is never promised as a cure.
The stressors specific to your work
- •Emotional labor with 100+ students daily and their families
- •Chronic underpay relative to credential level and workload
- •Administrative paperwork and standardized-testing pressure that displaces actual teaching
- •Parent communication often weighted toward complaints
- •Post-pandemic burnout layered on pre-existing pressures
- •Vicarious trauma from students' difficult home situations
Why telehealth works for teachers
- •Sessions scheduled evenings or weekends — no need for substitute teachers
- •No commuting to clinic — fits between school day and family time
- •Treatment in your own home — no risk of being seen by students or parents
- •Same physician every visit — continuity matters with limited mental bandwidth
- •Compatible with summer breaks and academic calendars
Privacy considerations
- •Tovani is direct-pay — no insurance claim tied to district health plan
- •Patient records are private and never accessible to your school, district, or union without your explicit written authorization
- •License renewal questions vary by state but typically do not require disclosure of standard outpatient mental health treatment
- •Treatment is documented in your private medical record and not visible to school health-program databases
5-minute screening · Reviewed by a board-certified physician · FL & NJ · $349/month
Frequently asked
Will my district find out?
No. Tovani is a private direct-pay practice — there's no insurance claim tied to your district plan, no record visible to your employer or union, and no information shared with school administrators. Your treatment is documented in your private medical record only, with HIPAA protections.
Do I have to take time off for sessions?
No. Telehealth sessions are scheduled evenings or weekends so you don't need a substitute teacher or to use sick leave. Sessions are typically 1-2 hours including the dosing and integration period.
Does ketamine therapy affect my ability to teach?
No. The dissociative effects of ketamine last only during the dosing window (1-2 hours) plus a brief recovery period. By the next morning you're fully back to baseline. Many teacher-patients report improved emotional regulation and patience in the classroom within weeks of starting treatment.
I'm burned out, not depressed. Will this help?
The clinical line between "burnout" and "depression" is blurrier than most people realize — they share many features and treatments. If standard interventions (rest, therapy, schedule changes) haven't produced enough recovery, professional evaluation can identify whether you meet depression criteria and whether ketamine is appropriate. Many "burnout" patients are clinically depressed.
What about during the school year vs summer?
Either timing works. Many teachers prefer summer for the initial treatment phase (more flexibility) and then transition to monthly maintenance during the school year. Others start during the school year because waiting until summer means accepting another semester of symptoms. Your physician can help time treatment around your schedule.
References
- Murrough JW et al. 2013, American Journal of Psychiatry. Ketamine RCT showed 64% response vs 28% placebo in treatment-resistant depression — relevant for chronic-burnout populations where SSRIs alone often produce partial response. PMID 23982301
- Sanacora G et al. 2017, JAMA Psychiatry. APA consensus on ketamine in mood disorders — addresses high-functioning patients with chronic stress who have not responded to first-line treatments. PMID 28249076